JP2002511864A5 - - Google Patents

Download PDF

Info

Publication number: JP2002511864A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

JP1999504389A

Other languages

English (en)

Other versions

JP2002511864A (ja

Filing date

1998-04-08

Publication date

2005-12-02

1997-06-23 Priority claimed from US08/880,945 external-priority patent/US5929055A/en

1998-04-08 Application filed filed Critical

2002-04-16 Publication of JP2002511864A publication Critical patent/JP2002511864A/ja

2005-12-02 Publication of JP2002511864A5 publication Critical patent/JP2002511864A5/ja

Status Ceased legal-status Critical Current

Description

JP50438999A 1997-06-23 1998-04-08 糖尿病管理のための治療方法 Ceased JP2002511864A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/880,945		1997-06-23
US08/880,945 US5929055A (en)	1997-06-23	1997-06-23	Therapeutic method for management of diabetes mellitus
PCT/US1998/006927 WO1998058658A1 (en)	1997-06-23	1998-04-08	Therapeutic method for management of diabetes mellitus

Publications (2)

Publication Number	Publication Date
JP2002511864A JP2002511864A (ja)	2002-04-16
JP2002511864A5 true JP2002511864A5 (ja)	2005-12-02

Family

ID=25377455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP50438999A Ceased JP2002511864A (ja)	1997-06-23	1998-04-08	糖尿病管理のための治療方法

Country Status (9)

Country	Link
US (1)	US5929055A (ja)
EP (1)	EP1017414A4 (ja)
JP (1)	JP2002511864A (ja)
KR (1)	KR20010020497A (ja)
AU (1)	AU744846B2 (ja)
CA (1)	CA2294169A1 (ja)
IL (1)	IL133643A0 (ja)
MX (1)	MXPA99011821A (ja)
WO (1)	WO1998058658A1 (ja)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP9902721A2 (hu) *	1997-11-25	1999-12-28	The Procter & Gamble Co.	Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
AU759372B2 (en) *	1998-09-28	2003-04-10	Research Foundation Of The State University Of New York, The	A novel inhibitor of cataract formation
US6914057B1 (en)	1998-09-28	2005-07-05	The Research Foundation Of State University Of New York	Inhibitor of cataract formation
EP1385549A2 (en) *	2001-03-12	2004-02-04	Novartis AG	Combination of nateglinide or repaglinide with at least one further antidiabetic compound
NZ529308A (en) *	2001-04-05	2005-03-24	Collagenex Pharm Inc	Tetracycline compounds comprising a tetracycline and a controlled release agent to provide delivery at a dose below that required for antibiotic activity
FR2826278B1 (fr) *	2001-06-20	2005-03-25	Lipha	Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
AU2002319381A1 (en) *	2001-06-20	2003-01-21	Merck Sante	Use of antidiabetics for making a medicine with cicatrizing effect
EP2301915A1 (en)	2001-07-13	2011-03-30	Paratek Pharmaceuticals, Inc.	7-(diethylamino)methyl substituted tetracycline having target therapeutic activities
JP2005539208A (ja) *	2001-12-21	2005-12-22	スミスクラインビーチャムコーポレーション	グルコース産生を変化させるための組成物および方法
EP2311797A1 (en)	2002-01-08	2011-04-20	Paratek Pharmaceuticals, Inc.	4-dedimethylamino tetracycline compounds
CN102531948A (zh)	2002-03-08	2012-07-04	帕拉特克药品公司	氨基-甲基取代的四环素类化合物
WO2003079984A2 (en)	2002-03-21	2003-10-02	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds
EP1534300A4 (en)	2002-07-12	2008-04-23	Paratek Pharm Innc	TETRACYCLINE COMPOUNDS SUBSTITUTED IN 3, 10, AND 12A
PT1615622E (pt)	2003-04-07	2012-10-17	Supernus Pharmaceuticals Inc	Formulações de doxiciclinas de dose única diária
JP4738333B2 (ja)	2003-07-09	2011-08-03	パラテックファーマシューティカルズインコーポレイテッド	９−アミノメチルテトラサイクリン化合物のプロドラッグ
EP2298323A3 (en)	2003-07-09	2011-05-11	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds
EP1716101A1 (en) *	2004-01-15	2006-11-02	Paratek Pharmaceuticals, Inc.	Aromatic a-ring derivatives of tetracycline compounds
EP2284150A3 (en)	2004-10-25	2011-09-21	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds
EP2301916A3 (en)	2004-10-25	2011-09-28	Paratek Pharmaceuticals, Inc.	4-aminotetracyclines and methods of use thereof
JP2009502809A (ja) *	2005-07-21	2009-01-29	パラテックファーマシューティカルズインコーポレイテッド	１０−置換テトラサイクリンおよびその使用方法
US20070098763A1 (en) *	2005-10-11	2007-05-03	Sinnott Robert A	Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
KR101538175B1 (ko)	2006-12-21	2015-07-20	파라테크 파마슈티컬스, 인크.	박테리아, 바이러스 및 기생충 감염의 치료를 위한 테트라시클린 유도체
US8513223B2 (en) *	2006-12-21	2013-08-20	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds for treatment of inflammatory skin disorders
EP2144870A2 (en) *	2007-04-27	2010-01-20	Paratek Pharmaceuticals, Inc.	Methods for synthesizing and purifying aminoalkyl tetracycline compounds
EP2192111A3 (en) *	2007-07-06	2010-10-06	Paratek Pharmaceuticals, Inc.	Methods for synthesizing substituted tetracycline compounds
TW202332671A (zh) *	2008-05-23	2023-08-16	美商ＰｒｔｋＳｐｖ２公司	四環素化合物之甲苯磺酸鹽及同素異形體
NZ603568A (en)	2008-08-08	2014-05-30	Tetraphase Pharmaceuticals Inc	C7-fluoro substituted tetracycline compounds
DK2427425T3 (en)	2009-05-08	2017-06-12	Tetraphase Pharmaceuticals Inc	tetracycline
CN102596898B (zh)	2009-08-28	2016-01-27	四相制药公司	四环素类化合物
DK2552890T3 (en)	2010-03-31	2017-04-03	Tetraphase Pharmaceuticals Inc	POLYCYCLIC TETRACYCLINE COMPOUNDS
NZ705849A (en)	2012-08-31	2018-06-29	Tetraphase Pharmaceuticals Inc	Tetracycline compounds
US9171343B1 (en)	2012-09-11	2015-10-27	Aseko, Inc.	Means and method for improved glycemic control for diabetic patients
US9897565B1 (en)	2012-09-11	2018-02-20	Aseko, Inc.	System and method for optimizing insulin dosages for diabetic subjects
US9898585B2 (en)	2014-01-31	2018-02-20	Aseko, Inc.	Method and system for insulin management
US9486580B2 (en)	2014-01-31	2016-11-08	Aseko, Inc.	Insulin management
US11081226B2 (en)	2014-10-27	2021-08-03	Aseko, Inc.	Method and controller for administering recommended insulin dosages to a patient
US9892234B2 (en)	2014-10-27	2018-02-13	Aseko, Inc.	Subcutaneous outpatient management
EP3337402A4 (en)	2015-08-20	2019-04-24	Aseko, Inc.	THERAPY ADVISER FOR THE MANAGEMENT OF DIABETES
DK3529236T3 (da)	2016-10-19	2024-05-13	Tetraphase Pharmaceuticals Inc	Krystalformer af eravacyclin
WO2020097450A1 (en)	2018-11-09	2020-05-14	Tetraphase Pharmaceuticals, Inc.	Polymorphic forms of a compound and uses thereof
MX2021013901A (es)	2019-05-14	2022-04-12	Tyme Inc	Composiciones y métodos para el tratamiento del cáncer.
EP4132561A4 (en) *	2020-04-08	2024-04-24	Hoffman Technologies LLC	METHODS FOR TREATING DISEASES CHARACTERIZED BY INSULIN DEFICIENCY IN ANIMALS
US10905698B1 (en)	2020-05-14	2021-02-02	Tyme, Inc.	Methods of treating SARS-COV-2 infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1985005036A1 (en) *	1984-04-30	1985-11-21	The Trustees Of Columbia University In The City Of	Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch
US5045538A (en) *	1990-06-28	1991-09-03	The Research Foundation Of State University Of New York	Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines
US5321008A (en) *	1991-01-10	1994-06-14	Amylin Pharmaceuticals, Inc.	Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
DE69304292T2 (de) *	1992-11-17	1997-01-02	Univ New York	Tetracycline inclusive nicht antimicrobiel wirksame, chemisch modifizierte Tetracycline hemmende exzessive Kollagenquervernetzung bei Diabetes
AU1209995A (en) *	1993-11-17	1995-06-06	Duke University Medical Center	Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
WO1996031242A1 (en) *	1995-04-07	1996-10-10	Albert Einstein College Of Medicine Of Yeshiva University	RECOMBINANT β-CELL AND USES THEREOF

1997
- 1997-06-23 US US08/880,945 patent/US5929055A/en not_active Expired - Lifetime
1998
- 1998-04-08 KR KR1019997012200A patent/KR20010020497A/ko not_active Application Discontinuation
- 1998-04-08 IL IL13364398A patent/IL133643A0/xx unknown
- 1998-04-08 AU AU68899/98A patent/AU744846B2/en not_active Ceased
- 1998-04-08 WO PCT/US1998/006927 patent/WO1998058658A1/en not_active Application Discontinuation
- 1998-04-08 MX MXPA99011821A patent/MXPA99011821A/es unknown
- 1998-04-08 CA CA002294169A patent/CA2294169A1/en not_active Abandoned
- 1998-04-08 JP JP50438999A patent/JP2002511864A/ja not_active Ceased
- 1998-04-08 EP EP98914580A patent/EP1017414A4/en not_active Withdrawn

Publication	Publication Date	Title
JP2000509942A5 (ja)	2007-09-06
JP2000510751A5 (ja)	2005-10-06
JP2000509637A5 (ja)	2005-10-06
JP2000509912A5 (ja)	2005-09-08
JP2000509635A5 (ja)	2005-10-06
JP2001513123A5 (ja)	2004-08-19
JP2000509587A5 (ja)	2005-09-08
JP2000510793A5 (ja)	2005-07-14
JP2000508866A5 (ja)	2005-09-08
JP2000508022A5 (ja)	2005-01-13
JP2002511864A5 (ja)	2005-12-02
JP2000508841A5 (ja)	2005-10-06
JP2000508680A5 (ja)	2005-11-24
JP2000509804A5 (ja)	2005-10-06
JP2002508773A5 (ja)	2006-10-26
JP2000509853A5 (ja)	2006-03-02
JP2002507327A5 (ja)	2005-12-22
JP2000510969A5 (ja)	2005-09-08
JP2000509755A5 (ja)	2005-10-06
JP2000508836A5 (ja)	2005-09-08
JP2000509520A5 (ja)	2005-09-08
JP2000510247A5 (ja)	2005-09-08
JP2000509818A5 (ja)	2004-10-28
JP2000507434A5 (ja)	2005-07-14
JP2002528037A5 (ja)	2005-12-08